Healthcare and life science company Arix Bioscience has appointed Dr Franz Humer as a senior independent director.
Most recently, Dr Humer served as chairman and chief executive at Roche, having joined the company as head of pharmaceuticals in 1995 before becoming chief operating officer in 1996.
He is currently chairman of Diageo, a consumer goods company, and a non-executive director of Chugai Pharmaceuticals, Citigroup and Kite Pharma.
Jonathan Peacock, chairman of Arix Bioscience, said: “We are delighted to welcome to the board a director of Franz’s stature.
“His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and innovative companies globally.
“Franz further strengthens a very experience board of executive and non-executive directors.”